Stoke Therapeutics Inc. (STOK) files mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts STOK Hot Sheet
Join SI Premium – FREE
Stoke Therapeutics Inc. (NASDAQ: STOK) has filed mixed shelf of:
Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Co-Diagnostics (CODX) files for 39.6M share offering by selling stockholders
- CoreCivic (CXW) Misses Q3 EPS by 1530c; raises guidance
- Nutrien (NTR) Declares $0.55 Quarterly Dividend; 3.1% Yield
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
